Patent · US Active

Intravenous infusion dosage form

US12403070B2 · kind B2 · utility

0Cited by
3References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 19, 2020
Grant dateSep 2, 2025
Priority date
Expiry dateJul 1, 2044

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61M5/14
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention refers to an intravenous infusion dosage form comprising a composition containing pemetrexed or its pharmaceutically acceptable salt, an osmagent and an aquous vehicle. The composition is present in a flexible infusion container containing an inert gas in the headspace. Additionally, a second container may be present surrounding the flexible infusion container.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.